Blast clearance after one week of corticosteroids correlates with outcome and genetics but does not justify adding a residual disease time point in acute lymphoblastic leukemia treatment.

导出 LinkOut

翻译打印收藏纠错

第一作者： Barbora,Vakrmanova

第一单位： Department of Paediatric Haematology and Oncology, Charles University, Second Faculty of Medicine, CLIP, Prague, Czech Republic.

作者： Barbora,Vakrmanova ^[1] ; Eva,Fronkova ^[1] ; Jan,Zuna ^[2] ; Iveta,Janotova ^[1] ; Yahia,Jabali ^[2] ; Leona,Rezkova Reznickova ^[2] ; Katerina,Zdrahalova ^[3] ; Jan,Trka ^[1] ; Jan,Stary ^[2] ; Ondrej,Hrusak ^[1] ; Ester,Mejstrikova ^[2]

作者单位： Department of Paediatric Haematology and Oncology, Charles University, Second Faculty of Medicine, CLIP, Prague, Czech Republic. ^[1] Department of Paediatric Haematology and Oncology, Motol University Hospital, Prague, Czech Republic. ^[2] Hospital Ceske Budejovice, Czech Republic. ^[3]

主题词肾上腺皮质激素类(Adrenal Cortex Hormones);人类(Humans);肿瘤, 残余(Neoplasm, Residual);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);治疗结果(Treatment Outcome)

DOI 10.1080/10428194.2020.1839659

PMID 33118409

发布时间 2021-04-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交